Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable NSCLC Published -- Download video MP4 360p Recommendations 1:25:15 Decoding Biomarker Testing and Targeted Therapy in NSCLC 1:03:18 Making Rounds: Medical Education Documentary Film 49:39 Advances in Endometrial Carcinoma Treatment: The Power of Immunotherapy and Other Emerging Regimens 53:53 The Latest in Immunotherapy to Treat Cancer 1:13:59 ProsTIC24- MDT PSMA PET 58:15 Current Management of Stage IIIA Non-Small Cell Lung Cancer: A Changing Paradigm (November 10, 2022) 3:11:52 Diagnosis of SVT in the EP lab 1:04:37 T cells, cancer and immunity 17:41 How I Learned I had Stage 4 Lung Cancer - Anne | The Patient Story 1:22:09 Illuminating the Path With Immunotherapy for Metastatic, Locally Advanced, and Early Stage NSCLC 51:47 Immunotherapy: What to Expect & Managing Side Effects 1:32:31 Unlocking the Power of Modern Therapeutic Regimens for Prostate Cancer 31:51 Lung Cancer Breakout: Breakthrough treatments for longer life 1:29:10 Multidirectional HCC Tactics: Expert Guidance on Emerging Trends With Systemic Therapy Options 03:58 16+ Years Cancer-Free Thanks to Immunotherapy: Sharon Belvin's Melanoma Story 08:30 What Does My Cancer Diagnosis ACTUALLY Mean? Similar videos 1:05:29 Can the Addition of Immunotherapy to Multimodal Management of Stage I-III NSCLC Improve Outcomes? 05:30 Resolving Practice Barriers to Consolidative Immunotherapy in Stage III NSCLC 44:56 Advanced NSCLC: Refining Clinical Pathways in the Rapidly Evolving Therapeutic Landscape 26:13 Immunotherapies in Lung Cancer | 2022 Evolution Conference 1:29:06 Leveraging Neoadjuvant and Adjuvant Immunotherapy to Improve Outcomes in Early-Stage Cancers 1:44:45 Gaining an Advantage Over NSCLC: How to Achieve the Greatest Benefit With Immunotherapy 01:06 Checkpoint Inhibitors Advance Standard of Care for Non-Small Cell Lung Cancers 1:06:01 Drs. Altorki & Spicer discuss immunotherapy advances in stage I-III NSCLC: https://bit.ly/3HVzzoZ 06:00 Ramucirumab plus pembrolizumab improves OS in advanced NSCLC 56:12 From concept to indication: Neoadjuvant immunotherapy for operable lung cancer 52:27 Immunotherapy/Checkpoint Inhibitor, Targeted Immunotherapy Drugs 5/2/18 1:00:44 Practical Application of Recent Clinical Data for Immunotherapy in NSCLC 02:27 Study finds neoadjuvant nivolumab to show long-term benefit in patients with NSCLC 1:00:18 Improving Clinical Care With Newer Better Therapies for Targeting Actionable gene Fusions in NSCLC 05:36 Treatment of Early-Stage NSCLC 31:50 Current & future considerations for the use of immune checkpoint inhibitors in NSCLC More results